MaxCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of MaxCyte using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.11 | $-0.12 | 8.33 % |
Jun 2024 | 2024-08-06 | $-0.09 | $-0.13 | 30.8 % |
Mar 2024 | 2024-05-07 | $-0.09 | $-0.13 | 30.8 % |
Dec 2023 | 2024-03-12 | $-0.05 | $-0.07 | 28.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $8.16M | $7.37M | 10.8 % |
Jun 2024 | 2024-08-06 | $10.43M | $7.92M | 31.7 % |
Mar 2024 | 2024-05-07 | $11.34M | $7.46M | 52.0 % |
Dec 2023 | 2024-03-12 | $15.67M | $13.09M | 19.7 % |
MaxCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
MaxCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.11, which beat the estimate of $-0.12.
MaxCyte ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.